Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: A retrospective cohort study

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 223-230

  Claydon Platt, Kate ^a   Manias, Elizabeth ^a   Dunning, Trisha ^a  

^a THE UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Diabetes; Hospital admission; Medication related problems; Risk factors

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AGE; AGED; ARTICLE; AUSTRALIA; BEHAVIOR DISORDER; COMORBIDITY; DIABETES MELLITUS; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION ERROR; MENTAL DISEASE; PREVALENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AUSTRALIA; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HUMANS; HYPOGLYCEMIA; LOGISTIC MODELS; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT COMPLIANCE; PRESCRIPTION DRUG MISUSE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84865071585     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.03.003     Document Type: Article

References (54)

1. Australian Council for Safety and Quality in Health Care Second national report on patient safety: improving medication safety 2002, Author, Canberra, Australia, p. 1-101.
2. Langford B.J., et al. Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center. Pharmacotherapy 2006, 26(2):260-268.
3. Roughead E.E. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999, 19(1):19-22.
4. Australian Institute of Health and Welfare Australian hospital statistics 1999-2000. Health services series no. 17 2002, Author, Canberra, Australia.
5. Bates D.W., et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. J Am Med Assoc 1995, 274(1):29-34.
6. Vincent C., Neale G., Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. Br Med J 2001, 322(1395):517-519.
7. Runciman W.B., et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003, 15(Suppl. 1):i49-i59.
8. Morimoto T., et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004, 13(4):306-314.
9. Miller G.C., Britt H.C., Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006, 184(7):321-324.
10. Yang Y., et al. Predictors of medication nonadherence among patients with diabetes in medicare Part D programs: a retrospective cohort study. Clin Ther 2009, 31(10):2178-2188.
11. Bolton P., Hammoud S., Leung J. Issues in quality use of medicines in two non-English speaking background communities. Aust J Primary Health 2002, 8(3):75-80.
12. Australian Institute of Health and Welfare Diabetes: Australian facts 2008 2008, Author, Canberra, Australia, p. 1-130.
13. UK Department of Health Health survey for England 1999: the health of minority ethnic groups 2001, Department of Health, London, p. 395.
14. Wild S., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
15. United States Department of Health and Human Services and National Center for Health Statistics National diabetes information clearinghouse (NDIC) - national diabetes statistics 2011.
16. World Health Organisation and National Centre for Classification in Health-University of Sydney International classification of diseases, 10th revision Australian modification (ICD-10-AM) 2000, Author, Geneva, Switzerland.
17. Australian Bureau of Statistics Birthplace of overseas-born Australians 2006, Available from:, [cited 10.11.06]. http://www.abs.gov.au/.
18. Charlson M.E., et al. A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation. J Chronic Dis 1987, 40(5):373-383.
19. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613-619.
20. Sundararajan V., et al. New ICD-10 version of the Charlson Comorbidity Index predicts in hospital mortality. J Clin Epidemiol 2004, 57(12):1288-1294.
21. Australian Bureau of Statistics 2001 Census of population and housing - SEIFA 2001 2001, Available from:, [cited 04.09.06]. http://www.abs.gov.au/.
22. State Government of Victoria Department of Health. Victorian Admitted Episode Dataset (VAED), December 13, 2007. p. 1-171. Available from: ; 2006 [cited 27.09.07]. http://www.health.vic.gov.au/hdss/vaed/2006-07/manual/index.htm.
23. Microsoft Corporation Office excel professional edition 2003, Author, Redmond, WA.
24. SPSS Inc. Statistical package for the social sciences (SPSS) 2005, Author, Chicago, IL.
25. Kirkwood B.R., Sterne J.A.C. Essential medical statistics 2003, Blackwell Publishing, Oxford, United Kingdom. 2nd ed.
26. Petrie A., Sabin C. Medical statistics at a glance 2005, Blackwell Publishing, Oxford, United Kingdom, p. 1-157. 2nd ed.
27. Pallant J. SPSS survival manual a step by step guide to data analysis using SPSS 2005, Allen and Unwin, Sydney, Australia, p. 1-317. 2nd ed.
28. Skrondal A., Rabe-Hesketh S. Some applications of generalized linear latent and mixed models in epidemiology: repeated measures, measurement error and multilevel modeling. Norwegian J Epidemiol 2003, 13(2):265-278.
29. Hedeker D. Generalized linear mixed models. Encyclopedia of statistics in behavioral science 2005, Wiley, New York. B. Everitt, D. Howell (Eds.).
30. ® 2007, Author, Hertfordshire, United Kingdom.
31. Winterstein A.G., et al. Preventable drug-related hospital admissions. Ann Pharmacother 2002, 36(7-8):1238-1248.
32. Quality use of medicines alert - subcutaneous insulin 2008, Quality Use of Medicines, Melbourne, p. 1. Quality Use of Medicines Program, Victoria Medicines Advisory Committee and State Government of Victoria (Eds.).
33. Pirmohamed M., et al. Adverse drug reactions as cause of admission to hospital: Perspective analysis of 18,820 patients. Br Med J 2004, 329(7456):15-19.
34. Woods D.M., et al. Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care 2007, 16(2):127-131.
35. Elliott W.J. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens 2009, 11(7):376-382.
36. Denhaerynck K., et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007, 7(1):108-116.
37. Kando J.C., Yonkers K.A., Cole J.O. Gender as a risk factor for adverse events to medications. Drugs 1995, 50(1):1-6.
38. Tran C., et al. Gender differences in adverse drug reactions. J Clin Pharmacol 1998, 38(11):1003-1009.
39. Davis D.P., et al. Demographic, socioeconomic, and psychological factors related to medication non-adherence among emergency department patients. J Emerg Med 2009.
40. Vlasnik J.J., Aliotta S.L., DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager 2005, 16(2):47-51.
41. Ahmed A.T., Karter A.J., Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med 2006, 23(7):795-802.
42. Gove W.R. Gender, marital status, and mortality. Am J Sociol 1973, 79(1):45-67.
43. Rogers R.G. Marriage, sex, and mortality. J Marriage Fam 1995, 57(2):515-526.
44. Ajzen I., Fishbein M. Understanding attitudes and predicting social behaviour 1980, Prentice-Hall, Englewood Cliffs, NJ, p. 1-278.
45. Strömberg A., et al. Factors influencing patient compliance with therapeutic regimens in chronic heart failure: a critical incident technique analysis. Heart Lung 1999, 28(5):334-341.
46. Yamada K., et al. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Res 2006, 141(1):61-69.
47. Mackin R.S., Arean P.A. Cognitive and psychiatric predictors of medical treatment adherence among older adults in primary care clinics. Int J Geriatr Psychiatry 2007, 22(1):55-60.
48. Ciechanowski P.S., Katon W.J., Russo J.E. Depression and diabetes. Impact of depressive symptoms on adherence, function and costs. Arch Intern Med 2000, 160(21):3278-3285.
49. Nageotte C., et al. Medication compliance among the seriously mentally ill in a public mental health system. Soc Psychiatry Psychiatr Epidemiol 1997, 32(2):49-56.
50. Peyrot M., McMurry J.F., Kruger D.F. A biopsychosocial model of glycemic control in diabetes; stress, coping and regimen adherence. J Health Soc Behav 1999, 40(2):141-158.
51. Schlundt D.G., Stetson B.A., Plant D.D. Situation taxonomy and behavioral diagnosis using prospective self-monitoring data: application to dietary adherence in patients with type 1 diabetes. J Psychopathol Behav Assess 1999, 21(1):19-36.
52. Australian Institute of Health, Welfare B., Tong C., Stevenson Comorbidity of cardiovascular disease, diabetes and chronic kidney disease in Australia, in cardiovascular disease series no. 28 2007, Author, Canberra, Australia, p. 1-79.
53. Starfield B., et al. Comorbidity: Implications for the importance of primary care in 'case' management. Ann Fam Med 2003, 1(1):8-14.
54. Struijs J.N., et al. Comorbidity in patients with diabetes mellitus: Impact on medical health care utilization. BMC Health Serv Res 2006, 6(84):1-9.